Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY) announced it has entered into a product purchase and supply agreement with the specialty pharmacy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE